Veristat
-
Radnor Drug Designer Certara Sells Medical Writing Business
Radnor-based drug developer Certara is selling its regulatory and medical writing business for up to $135 million to Veristat, writes John George for Philadelphia Business…
Founding Partners
Advertisement
Affiliate Partners
Chamber Partners
